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BACKGROUND: Non-invasive detection of atherosclerosis is critical for its prevention. 
Objective: To correlate non-invasively detectable indicators of coronary atherosclerosis, or Coronary Artery Disease (i.e., classical 
risk factors, hs-CRP test results, carotid intima-media thickness, endothelial function, ankle-brachial index and calcium score by 
computed tomography) with the extent of coronary disease assessed by the Friesinger index from conventional coronary angiography. 
METHODS: We conducted a prospective study of 100 consecutive patients, mean age 55.1 ± 10.7 years, 55% men and 45% women. 
Patients with acute coronary syndrome, renal dialytic insufficiency, collagen disease and cancer were not included. All patients were 
subjected to clinical evaluation and laboratory tests. Endothelial function of the brachial artery and carotid artery were evaluated by 
high-resolution ultrasound; ankle-brachial index and computed tomography for coronary determination of calcium score were also 
performed, and non-HDL cholesterol and TG/HDL-c ratio were calculated. All patients were subjected to coronary angiography 
at the request of the assistant physician. We considered patients without an obstructive lesion (< 29% stenosis) demonstrated by 
coronary angiography to be normal. 
RESULTS: Univariate analysis showed that calcium score, HDL-c, TG/HDL ratio and IMT were significantly correlated with the 
Friesinger index. However, multivariate analysis indicated that only calcium score and low HDL-c levels correlated significantly 
with the extension of CAD. On the other hand, hs-CRP, LDL-c, flow-mediated dilation, and Framingham score did not correlate 
with the Friesinger index. ROC analysis showed that calcium score, HDL-c and TG-HDL ratio accurately predicted extensive CAD 
in a statistically significant manner. 
CONCLUSION: It is possible to approximately determine the presence and extent of CAD by non-invasive methods, especially 
by calcium score, HDL-c and TG/HDL-c ratio assays.
KEYWORDS: Risk factors; Lipids; C-reactive protein; Tomography; Atherosclerosis 
INTRODUCTION
Atherosclerosis is an inflammatory disease that affects 
all arteries and can lead to ischemia of the heart, brain or 
extremities.1 It is the result of complex interactions between 
genetic and environmental factors which induce the arterial 
wall to respond to stimuli through the action of endothelial 
cells, smooth muscle, inflammatory cells and platelets,1 
leading to formation of plaques. The initial stages occur 
among children and young people and are silent and progress 
slowly; clinical manifestations generally appear in middle 
age.2 However, the first event triggered by atherosclerosis 
can be fatal. Recently, there has been an increase in 
recognition of the importance of subclinical atherosclerosis. 
For instance, elderly people with subclinical disease have 
a worse prognosis than those without this disease early 
disease.3 Furthermore, progression of atherosclerosis can 
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be significantly reduced when dyslipidemia is treated by 
statins;4 reduction in cardiovascular events after statin 
treatment has also been widely documented.5
Therefore, non-invasive documentation of atherosclerotic 
lesions has become an important objective for early 
treatment as well as preventive measures. Many strategies 
have been proposed to this end, but a thorough comparison 
of these approaches is still incomplete. Here, we sought 
to compare clinical indicators, laboratory tests and direct 
arterial vessel indices with standard coronary angiography to 
determine their ability to predict the extent of CAD.
METHODS
One hundred consecutively admitted patients of both 
sexes who underwent coronary angiography for diagnostic 
purposes between January 2005 and July 2007 were 
enrolled in our prospective study. All patients signed a 
form indicating their informed consent and underwent a 
clinical exam. Measurements of total cholesterol, HDL-c, 
LDL-c, triglycerides, fasting plasma glucose and hs-
CRP were also taken for each patient. Non-invasive tests 
included endothelial function studies, carotid ultrasound, 
calcium scoring by multislice coronary tomography and 
measurement of the ankle-brachial index. Exclusion criteria 
were acute coronary syndromes, atrial fibrillation, cancer, 
obstructive pulmonary illness, dialytic renal insufficiency or 
collagen illnesses. The research protocol was approved by 
the Ethics Committee of our institution. 
Clinical evaluation: Subjects were categorized as 
smokers if they reported smoking any number of cigarettes 
within the six months before the study; otherwise they were 
labeled as non-smokers. Subjects were defined as having 
hypertension if they displayed a sitting systolic blood 
pressure ≥130 mmHg, diastolic blood pressure of >85 
mmHg, or reported use of pressure-lowering medication. 
Diabetes mellitus was considered present if the subject 
reported current use of oral hypoglycemiant or insulin, or 
presented with fasting glucose levels above 126 mg/dL. 
Family history of hypertension was defined as a history 
of coronary disease in first first-degree relatives occurring 
before 55 years of age in men and 60 years of age in women. 
Weight, height and waist circumference were taken, and 
BMI was calculated for all subjects. Endothelial function, 
carotid intima-media thickness and ankle-brachial index 
study were assessed as described below.
Endothelial function was evaluated by flow-mediated 
dilation (FMD) in the left brachial artery. The left brachial 
artery was scanned with an ultrasound probe over a 
longitudinal section 3 to 5 cm above the right elbow. 
A pneumatic tourniquet was placed around the forearm 
distal to the target artery, then inflated to 250 mmHg and 
maintained for 5 min. Vessel recovery was assessed by 
a further resting scan 15 min later. Sublingual nitrate (5 
mg) was administered, and a final scan was performed 
5 min later. The diameter of the brachial artery was 
measured from the anterior to the posterior interface 
between the media and adventitia at a fixed distance. The 
mean of end-diastole diameter was calculated from five 
cardiac cycles synchronized with the R-wave peaks on the 
electrocardiogram. The change in diameter was expressed 
as the percent change relative to that at the initial resting 
scan.6 The pulse wave velocity profile of blood flow was 
simultaneously recorded. All measurements were performed 
between 8:00 and 11:00 AM in a temperature-controlled 
room with the subjects in a resting, supine state. Subjects 
abstained from alcohol, caffeine, tobacco and food for 12 
h before the study. Long-acting vasoactive medications, 
including calcium channel blockers, ß-adrenergic blocking 
agents, nitrates and converting enzyme inhibitors were 
discontinued for 12 h before the study. A 7.5 MHz linear 
array ultrasound probe attached to an ultrasound system 
(ATL-APOGEE 800 Plus™) was used.
 The normal coefficients of variation in our laboratory 
were 5.84±0.25% for measurements of FMD and 
3.97±0.24% for measurements of NTG.7,8 The coefficient 
of variation for the reproducibility of the ultrasound was 
9.77±0.82% for determination of FMD and 7.24±0.49% for 
determination of NTG.7,8
Carotid B-mode ultrasonography and intima-media 
thickness assessment
Intima-media thickness of the bilateral common right and 
left carotid arteries was measured at 1 cm below the carotid 
artery bifurcationwith an ATL (APOGEE 800 Plus™) linear 
array probe (7.5 MHz) .9 Each common carotid artery was 
evaluated with the subject in the supine position and head 
turned slightly to the contralateral side. Images were gated 
to ECG, and seven acquired images were selected: one 
for calibration, three in the first 6 ms of the T wave (from 
three different beats) to determine the largest diameter, 
and three at peak of the R wave to determine the smallest 
diameter. All exams were videotaped with a VHS system. 
The measurements were performed with the aid of software 
specifically designed for analyses of diameter, arterial flow 
and intima-media thickness developed at The Heart Institute.
All images were interpreted by a technician who was 
specifically trained in the assessment of IMT. Images were 
also visually inspected for plaques. The thickest value was 
chosen for represent the IMT of each patient. Plaques were 
considered present if any IMT value was over1.0 mm. 
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Ankle-brachial index is the ratio of the systolic blood 
pressure (SBP) at the ankle to the SBP in the arm. It is 
assumed that the decrease of effective perfusion pressure 
distal to the stenosis is roughly proportional to the severity 
of the occlusive disease. A cuff size appropriate for arm 
size was used for the brachial and ankle SBP. A hand-held 
Doppler was used to assess bilateral brachial, tibial and 
dorsalis pedis arteries. At each ankle (right and left), the 
higher of the two pressures measured in each leg was used 
as the numerator for same-side ABI calculation.10,11 
Laboratory measurements Blood samples for lipid 
measurements were drawn after the subject had fasted 
for 12 h. Total cholesterol and triglyceride serum levels 
were measured with enzymatic methods. High-density 
lipoprotein levels was determined after precipitation of 
apolipoprotein B. Low-density lipoprotein cholesterol 
concentrations were computed using the Friedewald formula 
for triglyceride levels ≤350 mg/dL. Non-HDL cholesterol 
and Tg/HDL ratio were also calculated. High-sensitivity 
C-Reactive Protein (hs-CRP) levels were measured by latex 
immunonephelometry using Dade Behring™ reagents. 
Glucose levels were measured by colorimetric enzymatic 
methods using hexoquinase.
The Toshiba Multi-Slice Aquilion 64™ system was used 
to perform 64-Slice Multislice Computed Tomography. 
Images were obtained using a 64-slice (3 mm thickness) 
protocol with image acquisition triggered to 80% of the 
electrocardiographic RR interval while respiration was held. 
Calcium scores were calculated according to Agatston’s 
method12,13 using a workstation Vitrea TM2™ with software 
specific to and validated for the assessment. Trained scan 
readers were blinded to the study parameters. A focus of 
coronary calcium was defined as the presence of four or 
more contiguous pixels measuring >130 Hounsfield units. 
Total coronary calcium scores (CCS) were determined from 
the sum of individual scores of the four major epicardial 
coronary arteries. A scan was considered positive for CAD 
when the total CCS was >0.
Coronary Angiography: All patients had undergone 
coronary angiography within the previous six months. The 
time elapsed between angiography and the non-invasive 
measurements ranged from one week to six months; 
however, 98% were within four months. Most exams 
(95%) were performed in our hemodynamic laboratory, 
using Phillips systems (Intergris BH 3000) in the typical 
orthogonal projections and a percutaneous technique 
with arterial access by brachial or femoral arteries. The 
analyses were performed by a physician blinded to the 
study. We used the Friesinger index14 for assessment of the 
extent of coronary disease. The scores in this index range 
from 0 to 15. Each of the three main coronary arteries is 
scored separately from zero to five. The scores are: 0: no 
arteriographic abnormalities; 1: trivial luminal narrowing 
of <29%; 2: localized luminal narrowing of 30-68%; 3: 
multiple sites of luminal narrowing at 30-68%; 4: luminal 
narrowing of 69-100% without 100% occlusion of proximal 
segments; 5: complete (100%) obstruction of a proximal 
segment.
Statistics: The sample size was calculated assuming 
40% simultaneous occurrence of abnormal intima-media 
thickness and coronary disease. This indicated that analysis 
of a minimum of 80 patients was necessary to show a 
statistically significant association between these two 
variables; we included 100 patients to ensure a safe margin 
in the event of losses. Continuous variables were described 
by mean and standard deviation, and frequency distributions 
were used to describe non-continuous variables. Chi-square 
and non-parametric ANOVA (Kuskal-Wallis) analyses 
were used to assess association. Multivariate analysis was 
performed by logistic regression.
RESULTS
Clinical characteristics: The clinical characteristic of 
the patients are summarized in Table 1. Of our 100 subjects, 
63 patients presented with obstructive CAD, and 37 showed 
no coronary lesions. The mean age was 55.1±10.7 years; 
55% of subjects were men, and 45% were women. Arterial 
hypertension was present in 75%, dyslipidemia in 47% and 
diabetes mellitus in 28%. Smokers made up 15% of the 
sample. 
Table 2 shows the results of laboratory tests. Thirty-
eight patients (38%) had LDC-c ≥ 130 mg/dL. These 
measurements varied somewhat by gender; 36 of 45 women 
(80%) had HDL-c <50 mg/dL, while only 24 of 55 (43.6%) 
men had values <40 mg/dL. Hs-CRP values were over 5 
mg/L in 16 (18.3%) subjects. Framingham scores indicated 
low risk for 17.4% of subjects, intermediate risk for 48.8% 
and high risk for 33.8%. Triglyceride values were >150 mg/
dL in 44 patients (44%). 
Table 3 shows the results of non-invasive indices. Flow-
mediated dilation (FMD) was above 8% in 11 men (13%) 
and above 10% in six women (7.1%). IMT values were 
below 1.0 mm in 58 patients (67.4%) and above 1.0 mm 
in 28 patients (32.5%). The TG/HDL ratio was <3.75 in 53 
patients (53%) and >3.75 in 47 patients (47%). 
Patients were given appropriate medications to control 
coronary disease as shown in Table 1.
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Exploratory statistic tests 
There was a weak positive correlation between 
Framingham score and age (R²=0.194). When Framingham 
score and IMT (dichotomized at 1 mm) were cross-tabulated, 
a borderline positive association was observed (p=0.053). 
Univariate analysis indicated a positive association 
(p=0.004) between extensive coronary atherosclerosis 
defined by Friesinger index ≥ 5 and abnormal IMT. 
The univariate analyses of the linear to linear association 
between extensive coronary disease (Friesinger index ≥ 5) 
and quartiles of calcium score and lipid profile presented 
the following results: quartiles of calcium score, p<0.0001; 
quartiles of HDL, p=0.0001; quartiles of TG/HDL-c, 
p=0.002; quartiles of total cholesterol, p=0.007 (this 
correlation was inconsistent due to the negative correlation 
between total cholesterol quartiles and the presence of 
extensive coronary disease, i.e., there were fewer patients 
with extensive coronary disease in the third and fourth 
cholesterol quartiles); quartiles of LDL, p=0.06; quartiles 
of triglycerides, p=0.414. When the strength of the same 
variables for exclusion or indication of coronary lesions was 
tested, the results were as follows: calcium score, p=0.0001; 
HDL-c, p=0.003; TG/HDL-c, p=0.013; LDLc, p=0.293; total 
cholesterol, p=0.167; triglycerides, p=0.695. Thus, calcium 
score was the best discriminator for the extent and presence 
of coronary lesions, followed by HDL and TG/HDL ratio. 
These results are shown in Table 4.
Association strengths were tested by comparing the 
fourth and first quartiles, which showed the following 
statistically significant results: coronary calcium score 
OR 585, 95%CI (26.8-12784), p<0.0001; HDL-c OR 
0.11, 95%CI (0.03-0.39), p= 0.0007; TG/HDL-c OR 
5,5, 95CI(1,6-18,4), p=0.01. No significant statistical 
associations were found with other lipid variables.
The best correlation index was found between the 
Friesinger index and Agatston calcium score. Thus, patients 
with a zero calcium score had very low frequency of 
obstructive disease, and the Friesinger index increased with 
increasing calcium score (Fig. 1). HDL-c also exhibited 
Table 1- Clinical characteristics of patients
Characteristic N %
Patients 100 100
Age (years) 55.1± 10.7
Men 55 55
Coronary Angiography (Friesinger 
index)
0 37 37
1-4 7 7
5-9 32 32
10-15 24 24
HAS 75 75
DM 28 28
Dyslipidemia 36 36
Smoking 15 15
Previous AMI 30 30
Waist circumference (cm) 97.4 ± 9.9
BMI (kg/m²) 32.1± 36.5
Medications
Aspirin 90 90
Statin 70 70
Beta-blockers 62 62
Angiotensin-converting enzyme inhibitor 47 47
Nitrate 30 30
Calcium channel blockers 20 20
Diuretics 20 20
Oral hypoglicemiants/Insulin 20 20
Angiotensin I receptor block 6 6
Fibrates 4 4
Table 2- Laboratory test scores
N Mean ± SD
Cholesterol Total (mg/
dL)
100 200.5 ± 53.8
Non-HDL-c cholesterol 
(mg/dL)
100 154 ± 47.5
HDL-c (mg/dL) 100 45.9 ± 5.5
LDL-c (mg/dL) 100 122.8 ± 51.5
Triglycerides (mg/dL) 100 203.0 ± 339.3
TG/HDLc 100 5.5 ± 9.2
hs-CRP (mg/L) 86 4.9 ± 12.4
Glucose (mg/dL) 100 114.5 ± 51.0
Abbreviations: hs-CRP: high sensitivity c-reactive protein, TG: triglycer-
ides
Table 3- Non-invasive test results (mean ± SD)
N Mean ± SD
FMD (%) 84 4.8 ± 5.7
FID (%) 84 16.0 ± 8.07
IMT (mm) 90 0.77±0.22
ABI 89 1.05± 0.7
Agatston score 95 529.5 ± 930..9
Abbreviations: FMD: flow-mediated dilation, FID: flow-independent dila-
tion, IMT: intima-media thickness, ABI: ankle-brachial index.
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a significant negative relationship with Friesinger index 
(p=0.0001). Note that the Friesinger index is zero with 
HDL-c >50 mg/dL from median (Figure 1). A positive 
association was also observed between the Friesinger 
index and TG/HDLc ratio. Each increment of the ratio was 
accompanied by an increase of the extent of coronary disease 
(p=0.004) (Fig. 1). There was 28% discordance between 
TG/HDL-C and HDL-C, e.g., nine of 61 (14.8%) patients 
presented a normal TG/HDL-C ratio and low HDL-C, and 
19 of 39 (88.7%) patients exhibited abnormally elevated TG/
HDL-C ratio but normal HDL-C levels. This discrepancy 
was found in 14 of 56 (25%) patients with extensive 
coronary disease and in 19 of 49 (31.8%) of those with less 
extensive disease. 
Other variables, such as age, smoking, Framingham 
score, BMI, diabetes mellitus, total cholesterol, LDL-c, 
non HDL-c cholesterol, triglycerides, hs-CRP, FMD, waist 
circumference and ABI, were not significantly associated 
with extent of coronary disease as determined by Friesinger 
index.
Multivariate analyses (logistic regression) associated the 
following variables with the Friesinger index: calcium score, 
R=6.6, 95% CI: 3.16-13.72, p<0.0001; HDL-c, OR=0.30, 
95%CI: 0.18-0.51, p<0.0001. A significant association was 
also observed for TG/HDL ratio, OR=0.7, 95% CI: 0.48-
1.05, p=0.085. 
Analysis by the ROC curve 
The variables for which association remained statistically 
significant in multivariate analysis (i.e., calcium score, 
HDL-c and TG/HDL-c ratio) were analyzed by means of 
ROC curves to determine accuracy in detecting extensive 
coronary disease (Friesinger index ≥ 5). The variable with 
the greatest area under the curve was calcium score (92.7%), 
followed by HDL-c (71.1%) and TG/HDL-c ratio (68%). 
The cut-off point of the Agatston calcium score, which 
has a better profile of accuracy, was 55 that showed 81% 
sensitivity and 90% specificity Simulations at different 
cut-off points of Agatston calcium score, TG/HDL-C ratio 
and HDL-C showed the following coordinates of sensitivity 
and specificity: Agatston equal to zero: sensitivity 70%, 
specificity 96%; Agatston equal to 100: sensitivity 95%, 
specificity 60%; TG/HDL-c (3.75): sensitivity 61.5%, 
specificity 63%; and HDL-C 40 mg/dL: sensitivity 70%, 
specificity 65%.
Table 4- Frequency of extensive coronary disease (Friesinger index ≥ 5) by quartiles of coronary calcium score and lipid variables
CCS TC LDL HDL TG TG/HDL
Friesinger Index frequency (%)
0 ≥5 0 ≥5 0 ≥5 0 ≥5 0 ≥5 0 ≥5
Q1 84.4 6.3 24 76 24 72 26.9 73.1 48 44 56 32
Q2 41.2 47.1 40 56 46.2 50 20.8 72 23.1 65.4 38 53.8
Q3 8.3 83.3 40 56 34.6 61.5 37.5 54.2 41.7 54.3 28 68
Q4 0 100 44 36 43.5 39.1 64 24 36 60 25 70.2
Q = quartile
Figure 1 - Friesinger index boxplot distribution by Agatston quartiles, HDL-c 
quartiles and TG/HDL-c quartiles
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When ROC curves were constructed using quartiles 
of these variables, the following ideal points emerged: 
calcium quartile 2.5, corresponding to 90% sensitivity and 
80% specificity; TG/HDL-c ratio quartile 1.5 with 70% 
sensitivity and 60% specificity; HDL-C quartile 1.5 with 
75% sensitivity and 65% specificity. ROC curves are shown 
in Figure 2.
Since the calcium score was found to be the most 
sensitive and specific index for CAD detection, we also 
examined correlates of this variable. Agatston quartiles 
correlated positively with age (p<0.001) and IMT (p=0.002), 
however there was only a weak correlation with Framingham 
score (p=0.079). We did not find significant correlation 
between Agatston score and triglyceride level, HDL-c, non-
cholesterol HDL-c, hs-CRP, waist circumference, FMD, 
ABI, BMI, HAS, DM or Framingham score.
DISCUSSION 
The main findings of this study were that calcium 
score, HDL-C levels and TG/HDL-C ratio are the non-
invasive parameters most strongly associated with the 
extent of coronary disease as assessed by Friesinger index 
from conventional coronary angiography. Several aspects 
of this study deserve discussion. Our population is a 
sample of the so-called “real world” of CAD in Brazil. 
We enrolled patients who represented the entire spectrum 
of CAD; our subjects included patients with no CAD as 
well as individuals with extensive CAD. It should be noted, 
however, that a normal luminogram does not necessarily 
guarantee that those arteries are free of atherosclerosis. 
All patients enrolled in the study had some risk factors 
for CAD; 70% of them were already using lipid-lowering 
drugs in accordance with the guidelines for secondary 
prevention (64% of our population had proven CAD). 
The most prevalent risk factor was hypertension, followed 
by dyslipidemia and diabetes. Our risk factor prevalence 
were similar to that found by Escoteguy et al that studied 
another Brazilian sample except by our higher prevalence 
of hypertension15. Smoking was unrelated to the presence 
of obstructive CAD. The prevalence of smoking was lower 
than indicated in data from national surveys, that showed 
variation from 21% to 36% 16,17.This lower incidence may be 
due to secondary prevention in patients already being treated 
for coronary disease 
Framingham scores had no significant correlation with 
extent of CAD. However it might be antecipated because we 
studied a high risk population with indication of coronary 
angiography, e.g. we have worked with an homogenous 
population with a high prevalence of disease On the ohter 
hand Framingham score was designed to predict clinical 
coronary disease events but is not intended to correlate with 
coronary disease extension. 
Our patients had slightly increased levels of triglycerides 
and glucose, according to Brazilian guidelines for 
dyslipidemia and diabetes. Total cholesterol, HDL-c and 
LDL-c, were within normal limits, probably due to the 
use of statins in the majority of patients. However, 38% 
had LDL-C ≥130 mg/dL, which is considered high for the 
purposes of secondary prevention. Several studies have 
shown a correlation between CAD and those risk factors.18,19 
In the Framingham study,18 the risk of CAD is 4.9 times 
higher in diabetic women and 2.1 times higher in men with 
diabetes. Low HDL-C is also among the risk factors for 
the Framingham score, while high HDL-C protects against 
CAD.18 HDL-C levels were satisfactory and the analysis 
of HDL-C quartiles showed an inverse relationship with 
the extent of CAD. Thus lower levels of HDL-C coincide 
with a higher Friesinger index, in agreement with the 
Lipid Research Center20 and Framingham studies,18 and a 
low HDL-C level is an independent risk factor for CAD. 
In Brazil, Magalhaes21 evaluated 165 patients that had 
undergone coronary artery bypass grafting and showed 
that, of the factors they studied, HDL-C below 35 mg/
dL was the only independent predictor of mortality at five 
years. Although several studies have identified hs-CRP as 
a sensitive marker for coronary events,22 we did not find a 
correlation between hs-RCP and Friesinger index or calcium 
score. The observed low correlation in the present study may 
also be related to the use of statins among patients in our 
study group, as statins have anti-inflammatory properties.23 
Figure 2 - ROC curves by quartiles of Agatston, TG/HDL-c and HDL-c for 
patients with a Friesinger index ≥ 5
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The TG/HDL ratio correlated with Friesinger index but not 
with calcium score. We have no clear explanation for this 
paradox; increased TG/HDL ratio coincides with increased 
numbers of small and dense LDL particles that are more 
atherogenic, and thus subclinical atherosclerosis should be 
correlated with an abnormal ratio. However, ROC curves 
show that this relationship is of intermediate value. In a 
previous study of 374 patients, we also observed a significant 
correlation of elevated TG/HDL-C ratio with extensive 
CAD.24 We have also reported that high levels of TG/HDL-C 
ratio were associated with precocious manifestation of the 
disease in another 495 patients with CAD, demonstrating the 
clinical utility of this ratio.25 
Several correlations were tested between the Friesinger 
index and methods for the direct observation of coronary 
and peripheral arteries. Agatston score showed a positive 
correlation with the extent of coronary disease measured 
by the Friesinger index. These findings are consistent with 
studies that showed a higher incidence of coronary events 
in the presence of calcification of the coronary arteries.26 
Several studies also showed calcium score as an useful 
tool for risk stratification.27 Agatston score increased in 
proportion with increasing age; the same direct correlation 
was observed in a Brazilian study that showed a positive 
correlation between age and coronary calcium score (r = 
0.4, p <0.01).28
Framingham score was weakly correlated with calcium 
score. A metanalysis carried out in asymptomatic subjects 
showed that an above-average calcium score was associated 
with acute myocardial infarction and death.29 The predictive 
value of calcium score in patients at high risk is still 
unclear, but it is superior to that of traditional indices. 
The association of calcium score with Framingham score 
was assessed by Greenland et al.,30 who followed 1312 
asymptomatic, non-diabetic, middle age subjects 45 years 
or older for 8.5 years and found that a calcium score over 
300, as measured by coronary CT, was predictive of AMI 
or death from coronary artery disease (p<0.001), compared 
with a score of zero. Moreover, in subjects with Framingham 
scores higher than 10%, an increased calcium score indicates 
a greater likelihood of coronary events, while in individuals 
with Framingham scores of <10% this correlation did not 
occur. Therefore, in our study, calcium score emerged as the 
most important marker for both the presence and absence 
of CAD. 
Measures of IMT showed a mean value of 0.77 
mm, which we defined as normal. Subjects with carotid 
thickening (IMT ≥ 1.0 mm) exhibited a greater extent of 
coronary artery disease and a higher calcium score. These 
data confirm previous studies that showed a correlation 
between carotid intima-media thickness and increased 
cardiovascular event rates.31 For example, in the Kuopio 
Ischemic Heart Disease Risk Factor Study, the risk of acute 
myocardial infarction was shown to increase 11% for each 
increase of 0.1 mm in carotid IMT.32 
Neither arterial endothelium-dependent nor -independent 
dilation were correlated with Friesinger index or with 
calcium score. This finding contrasts with those of previous 
works33 and can not be easily explained; however, the use of 
statins among our subjects is a plausible explanation. The 
ankle-brachial index was abnormal in only 13 patients; seven 
had values ≤0.9, and six had values ≥1.3. No correlation 
between ankle-brachial index and Friesinger index or 
calcium score was observed. Although several studies show 
abnormal ABI to be a marker of peripheral arterial disease, 
and its presence to be associated with coronary events, we 
could not confirm these results here. 
In summary, we showed that a consistent estimate of 
the presence, extension or absence of coronary lesions by 
non-invasive methods is possible even in a cohort of real-
world patients. Of course, there is no absolute precision in 
these findings, only approximation. However, these results 
suggest that certain patients should undergo more thorough 
investigations, while others should not; our findings might 
also inform guidelines for preventive measures.
Limitations
All patients included in the project had multiple risk 
factors for CAD or were known to have CAD. Thus, this 
population does not include truly normal individuals. 
Furthermore, many of the study subjects were taking 
medications; 70% were on statins. Thus, this is a select 
population; this fact could influence the outcome of some 
tests such as those for endothelial function, the hs-RCP and 
blood lipids. However, it is presently almost impossible to 
find CAD patients who are not taking any medications. 
The mean age of the study group was 55 years, which is 
relatively low for the early detection of peripheral arterial 
disease. This may in part explain the absence of correlation 
between ABI and CAD. Despite these limitations, the study 
offers an objective, broad comparison of non-invasive tests 
for CAD detection and quantification.
CONCLUSIONS
Non-invasive methods can predict the presence and 
extent of coronary artery disease. Coronary calcium score 
was the most accurate predictor, followed by HDL-c levels 
and the triglyceride:HDL-c ratio. 
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